Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine / Maurizio Fava en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 365-369 Título : Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine Tipo de documento: texto impreso Autores: Maurizio Fava, Autor ; Patrick J. McGrath, Autor ; Wang Pui Sheu, Autor Fecha de publicación: 2023 Artículo en la página: pp. 365-369 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo mayor, Resistencia a los medicamentos, Fluoxetina, Morfolinas. Resumen: The aim of the present study was to evaluate the efficacy and safety of an immediate switch to reboxetine, a selective noradrenaline reuptake inhibitor (selective NRI), in patients with depression unresponsive to the selective serotonin reuptake inhibitor (SSRI) fluoxetine. Link: ./index.php?lvl=notice_display&id=31011 [artículo] Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine [texto impreso] / Maurizio Fava, Autor ; Patrick J. McGrath, Autor ; Wang Pui Sheu, Autor . - 2023 . - pp. 365-369. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 365-369 Palabras clave: Antidepresivos, Trastorno depresivo mayor, Resistencia a los medicamentos, Fluoxetina, Morfolinas. Resumen: The aim of the present study was to evaluate the efficacy and safety of an immediate switch to reboxetine, a selective noradrenaline reuptake inhibitor (selective NRI), in patients with depression unresponsive to the selective serotonin reuptake inhibitor (SSRI) fluoxetine. Link: ./index.php?lvl=notice_display&id=31011

---

1 (1 - 1 / 1)